Hyundai Bioscience Co., Ltd. (048410.KQ)
KRW 13990.0
(-1.82%)
KRW 13990.0
(-1.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.29 Billion | -16.76 Billion | -748.13 Million | 7.24 Billion | 8.89 Billion | 4.66 Billion |
| Net Income | -14.49 Billion | -15.8 Billion | -20.05 Billion | -8.25 Billion | 1.21 Billion | 3.1 Billion |
| Depreciation & Amortization | 1.43 Billion | 1.78 Billion | 2.7 Billion | 3.77 Billion | 3.81 Billion | 1.83 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 402.42 Million | 596.93 Million | 578.26 Million | 1.03 Billion | - | - |
| Change in working capital | 1.12 Billion | 1.44 Billion | 5.46 Billion | 7.7 Billion | 1.24 Billion | -405.96 Million |
| Other non-cash items | 7.54 Billion | -2.76 Billion | 11.27 Billion | 3.58 Billion | 8.47 Billion | 6.05 Billion |
| Investing Cash Flow | 5.17 Billion | 8.51 Billion | -12.35 Billion | -26.83 Billion | -14.69 Billion | -4.62 Billion |
| Investments in PPE | -587.53 Million | -1.54 Billion | -3.76 Billion | -25.2 Billion | -13.06 Billion | -7.06 Billion |
| Acquisitions | - | 13.19 Billion | - | -558.33 Million | -1.42 Billion | - |
| Investment purchases | - | -2.98 Billion | -13.01 Billion | -558.33 Million | -2.92 Billion | - |
| Sales/Maturities of investments | 6 Billion | 13.19 Billion | 1.82 Billion | 1.5 Billion | - | - |
| Other Investing Activities | -235 Million | -148.4 Million | 4.41 Billion | -2.56 Billion | 1.29 Billion | 2.43 Billion |
| Financing Cash Flow | 231.21 Million | 1.89 Billion | 3.2 Billion | 33.2 Billion | 8.16 Billion | -1.75 Billion |
| Debt repayment | -611.08 Million | -1.33 Billion | -833.36 Million | -33.66 Billion | -6.5 Billion | -1.75 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.09 Billion | 3.59 Billion | 4.44 Billion | - | 2.1 Billion | - |
| Other Financing Activities | 304.9 Million | -6.64 Million | -10.00 | -608 Million | 1.82 Billion | -2.97 Billion |
| Accounts receivables | 867.69 Million | 1.23 Billion | 4.38 Billion | 4.76 Billion | 2.54 Billion | -3.9 Billion |
| Accounts payables | -256.19 Million | 503.56 Million | 13.43 Million | 1.35 Billion | 1.44 Billion | 210.11 Million |
| Inventory | 358.12 Million | 403.6 Million | 864.9 Million | 1.86 Billion | -2.2 Billion | 1.43 Billion |
| Other working capital | 156.3 Million | -692.91 Million | 205.61 Million | -280.62 Million | -537.15 Million | 1.85 Billion |
| Cash at beginning of period | 2.73 Billion | 9.18 Billion | 19.21 Billion | 5.55 Billion | 3.16 Billion | 4.85 Billion |
| Cash at end of period | 1.81 Billion | 2.73 Billion | 9.18 Billion | 19.21 Billion | 5.55 Billion | 3.16 Billion |
| Capital Expenditure | -587.53 Million | -1.54 Billion | -3.76 Billion | -25.2 Billion | -13.06 Billion | -7.06 Billion |
| Effect of forex changes on cash | -31.72 Million | -103.42 Million | -122.28 Million | 37.94 Million | 30.73 Million | 37.37 Million |
| Net cash flow / Change in cash | -920.54 Million | -6.45 Billion | -10.02 Billion | 13.65 Billion | 2.39 Billion | -1.68 Billion |
| Free Cash Flow | -6.88 Billion | -18.3 Billion | -4.51 Billion | -17.96 Billion | -4.16 Billion | -2.4 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.3 Billion | 1.18 Billion | -8.08 Billion | -14.49 Billion | -1.97 Billion | -2.33 Billion |
| Depreciation & Amortization | 285.28 Million | 140.51 Million | 234.02 Million | 1.43 Billion | 347.39 Million | 419.42 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | -124.83 Million | 115.78 Million | 402.42 Million | 108.84 Million | 88.9 Million |
| Change in working capital | 10.99 Billion | -9.18 Billion | 1.85 Billion | 1.12 Billion | -595.01 Million | 745.15 Million |
| Other non-cash items | -5.78 Billion | 3.21 Billion | 3.9 Billion | 7.54 Billion | 1.48 Billion | 387.03 Million |
| Investing Cash Flow | -20.05 Billion | 9.88 Billion | -438.94 Million | 5.17 Billion | 974.61 Million | 2.15 Billion |
| Investments in PPE | -52.3 Million | -20.56 Million | -30.94 Million | -587.53 Million | -26.38 Million | -23.2 Million |
| Acquisitions | -20.08 Billion | - | - | - | - | - |
| Investment purchases | -6 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | 10 Billion | - | 6 Billion | 1 Billion | 2 Billion |
| Other Investing Activities | 87.81 Million | -91 Million | -408 Million | -235 Million | 1 Million | 182 Million |
| Financing Cash Flow | 31.2 Billion | 93.97 Million | 54.5 Million | 231.21 Million | -56.12 Million | -444.13 Million |
| Debt repayment | -83.17 Million | -33.97 Million | -35.77 Million | -611.08 Million | -103.72 Million | -527.77 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.26 Million | 127.95 Million | 18.73 Million | 1.09 Billion | 47.6 Million | 183.36 Million |
| Other Financing Activities | 31.28 Billion | 55.72 Million | -53.53 Million | 304.9 Million | -23.11 Million | -390.49 Million |
| Accounts receivables | 3.89 Billion | -4.92 Billion | 1.84 Billion | 867.69 Million | -573.97 Million | 523.4 Million |
| Accounts payables | -101.98 Million | -23.52 Million | -217.45 Million | -256.19 Million | 160.29 Million | -177.58 Million |
| Inventory | 115.68 Million | 1.99 Billion | -309.24 Million | 358.12 Million | -241.13 Million | 693.08 Million |
| Other working capital | 6.98 Billion | -6.23 Billion | 535.25 Million | 156.3 Million | 59.8 Million | -293.75 Million |
| Cash at beginning of period | 3.86 Billion | 1.81 Billion | 3.4 Billion | 2.73 Billion | 4.59 Billion | 3.45 Billion |
| Cash at end of period | 22.86 Billion | 3.86 Billion | 1.81 Billion | 1.81 Billion | 3.4 Billion | 4.59 Billion |
| Capital Expenditure | -52.3 Million | -20.56 Million | -30.94 Million | -587.53 Million | -26.38 Million | -23.2 Million |
| Effect of forex changes on cash | 47.98 Million | -48.78 Million | 39.36 Million | -31.72 Million | -20.86 Million | 3.55 Million |
| Net cash flow / Change in cash | 19 Billion | 2.05 Billion | -1.59 Billion | -920.54 Million | -1.18 Billion | 1.13 Billion |
| Free Cash Flow | 7.75 Billion | -7.9 Billion | -1.27 Billion | -6.88 Billion | -2.11 Billion | -608.78 Million |
NGL-PC
UDAICEMENT
KMNCF
195870
0989
005389